sees fy adjusted earnings per share $num-one to $num - two.
sees fy adjusted earnings per share $num-one to $num - two.
qtr-three adjusted earnings per share $num-one.
sees year-six net sales growth of num-one% to num-two%.
sees year-six organic sales growth of num-one% to num-two% on a reported basis.
sees fy year-six revenue growth of num-one% to num-two%.
qtrly organic sales increased num-one%.
qtr-three sales $num-one billion versus refinitiv ibes estimate of $1.06 billion.
sees fy year-six total sales $num-one billion to $3.0 billion.
qtrly organic sales increased num-one%.
qtrly adjusted operating profit down num-one% versus qtr-three of year-five.
qtrly k-c professional margins were down significantly, including an approximate num-one basis point drag from fixed costs under absorption.
qtrly organic sales rose num-one% in consumer tissue and num-two% in personal care.
qtr-three cash provided by operations $num-one million.
qtrly adjusted gross margin of num-one%, up num-two basis points year-over-year.
compname reports qtr-three earnings per share $num-one.
